[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  RedboxGlobal India [@REDBOXINDIA](/creator/twitter/REDBOXINDIA) on x 365.7K followers Created: 2025-05-15 11:29:06 UTC NEULAND LABORATORIES: Q4 CONS NET PROFIT 278.1M RUPEES VS 676M (YOY); 1.02B (QOQ) NEULAND LABORATORIES: Q4 REVENUE 3.28B RUPEES VS 3.8B (YOY) NEULAND LABORATORIES: Q4 EBITDA 510.7M RUPEES VS 1.07B (YOY) || Q4 EBITDA MARGIN XXXXX% VS XXXXX% (YOY) NEULAND LABORATORIES: CO RECOMMENDED FINAL DIVIDEND OF XX RUPEES PER EQUITY SHARE XXXXXX engagements  **Related Topics** [india](/topic/india) [Post Link](https://x.com/REDBOXINDIA/status/1922977534519673094)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RedboxGlobal India @REDBOXINDIA on x 365.7K followers
Created: 2025-05-15 11:29:06 UTC
NEULAND LABORATORIES: Q4 CONS NET PROFIT 278.1M RUPEES VS 676M (YOY); 1.02B (QOQ)
NEULAND LABORATORIES: Q4 REVENUE 3.28B RUPEES VS 3.8B (YOY)
NEULAND LABORATORIES: Q4 EBITDA 510.7M RUPEES VS 1.07B (YOY) || Q4 EBITDA MARGIN XXXXX% VS XXXXX% (YOY)
NEULAND LABORATORIES: CO RECOMMENDED FINAL DIVIDEND OF XX RUPEES PER EQUITY SHARE
XXXXXX engagements
Related Topics india
/post/tweet::1922977534519673094